Primer Ventures
Life science venture capital fund actively investing in early-stage (Series A, pre-A, B) disruptive life science tools and therapeutics companies.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
)